Connected Drug Delivery Devices Market Updates : to Grow at a CAGR of 24.3% from 2022 to 2030

Connected drug delivery devices refer to intelligent electronic tools that enable patients to self-administer therapy wirelessly. Utilizing mechanisms like auto-injectors, smart inhalers, and closed-loop solutions, these devices have shown promise in enhancing patient adherence and minimizing dosage errors, especially within a home environment. They find application in treating a range of conditions including multiple sclerosis, diabetes, liver and renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.

The connected drug delivery devices market size was $290.30 million in 2021, and is estimated to reach $2.1 billion by 2030, growing at a CAGR of 24.3% from 2022 to 2030.

CAGR: 24.3%
Current Market Size: USD 290.3 Million
Forecast Growing Region: APAC
Largest Market: North America
Projection Time: 2022 - 2030
Base Year: 2022

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/26467

𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧-
By Type
Injectable
Inhalation Devices

By Technology
Bluetooth
NFC
Others

By End-use
Homecare
Hospitals

By Region
North America (U.S., Canada, Mexico)
Europe (Germany, United Kingdom, France, Spain, Italy, Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia, Rest Of Asia Pacific)
LAMEA (Brazil, Saudi Arabia, UAE, South Africa, Rest of LAMEA)
Impact of COVID-19 on the Global Connected Drug Delivery Devices Market

The COVID-19 pandemic led to a slight downturn in the sales of connected drug delivery devices for medical device manufacturers. This decline can be attributed to disruptions in global distribution and sales channels. During the pandemic, limitations imposed on individuals resulted in a reduced rate of disease diagnosis and screening. Furthermore, the research and development efforts within the pharmaceutical industry were hindered, impacting market growth.

Nevertheless, the COVID-19 crisis underscored the necessity for accessible and secure homecare solutions. The demand for online connectivity devices rose, enabling healthcare professionals to remotely monitor a patient's medication. Consequently, these developments helped alleviate the adverse effects of the pandemic, allowing the market to sustain a steady growth trajectory.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (210 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/connected-drug-delivery-devices-market/purchase-options

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
Based on type, the injectable devices sub-segment emerged as a dominating leader in 2021 and the inhalation devices are anticipated to be the fastest growing sub-segment during the forecast period
Based on technology, the NFC sub-segment emerged as the fastest growing sub-segment and the Bluetooth sub-segment is predicted to be the dominating in the upcoming years
Based on end-user, the homecare settings sub-segment emerged as the fastest growing and the hospitals sub-segment is predicated as dominating in the market during the forecast period
Based on region, the North America market registered the highest market share in 2021 and Asia-Pacific region is anticipated to be the fastest growing in the market during the forecast period.
Connected Drug Delivery Devices Market Regional Analysis

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚:
In 2021, North America generated substantial revenue and is forecasted to maintain its dominance in the global connected drug delivery devices market over the projected period. This is primarily attributed to the region's advanced healthcare infrastructure, significant healthcare expenditure, the presence of key market players, and strategic partnerships. Additionally, the increasing prevalence of chronic diseases in the U.S. and a growing emphasis on preventive healthcare are expected to further fuel market growth in this region.
Asia-Pacific:

The Asia-Pacific region is witnessing significant opportunities for market growth due to factors such as growing awareness regarding connected drug delivery devices, cost advantages, and the rapid adoption of medical technology in countries like China and India. These factors contribute to the region's potential for considerable market expansion.
Rest of the World:

In other parts of the world, the connected drug delivery devices market is anticipated to gain traction due to the implementation of robust marketing strategies by market players, an increase in healthcare spending, and the projected expansion of distribution networks by key industry players.

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭 @ https://www.alliedmarketresearch.com/purchase-enquiry/26467

𝐊𝐞𝐲 𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Adherium
West Pharmaceutical Services, Inc.
Proteus Digital Health
AptarGroup Inc.
Cohero Health, Inc.
Ypsomed AG
F. Hoffmann-La Roche Ltd
BD
Syncro Technology Corp.
PROPELLER HEALTH

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/press-release/connected-drug-delivery-devices-market.html

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧-
𝐍𝐨𝐬𝐞 𝐑𝐞𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/nose-reconstruction-market-A13217

𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.